...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: How & who comes up with valuations?

we've seen several posts where Biotechs are being bought out with far less in the tank & quite expensive drugs so hence me having trouble with the valuation given for zenith, is it adding up for others?

Can someone please explain this huge disconnect.

Share
New Message
Please login to post a reply